|
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma |
|
|
|
Titel: |
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma |
Auteur: |
Morschhauser, F. Marlton, P. Vitolo, U. Lindén, O. Seymour, J.F. Crump, M. Coiffier, B. Foà, R. Wassner, E. Burger, H.-U. Brennan, B. Mendila, M. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 21 () nr. 9 pagina's 1870-1876 |
Jaar: |
2010 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|